Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation

Infection and Immunity

Volumn 77, Issue 6, 2009, Pages 2367-2375

  Antonopoulos, Dionysios A ^a   Huse, Susan M ^b   Morrison, Hilary G ^b   Schmidt, Thomas M ^c   Sogin, Mitchell L ^b   Young, Vincent B ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MARINE BIOLOGICAL LABORATORY   (United States)

^c Michigan State University ^*  (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CEFOPERAZONE; METRONIDAZOLE; SMALL SUBUNIT RIBOSOMAL RNA; ANTIINFECTIVE AGENT; BACTERIAL DNA; RIBOSOME DNA; RNA 16S;

ANIMAL EXPERIMENT; ARTICLE; BACTEROIDETES; COMMUNITY DYNAMICS; COMMUNITY STRUCTURE; CONTROLLED STUDY; DIET; ECOSYSTEM; FIRMICUTES; GASTROINTESTINAL DISEASE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; INTESTINE FLORA; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEOBACTERIA; SEQUENCE TAGGED SITE; STEREOTYPY; ANIMAL; BACTERIUM; BIODIVERSITY; C57BL MOUSE; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; GASTROINTESTINAL TRACT; GENETICS; MICROBIOLOGY; MOUSE MUTANT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIODIVERSITY; DNA, BACTERIAL; DNA, RIBOSOMAL; GASTROINTESTINAL TRACT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 66549102207     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01520-08     Document Type: Article

References (62)

1. Aas, J., C. E. Gessert, and J. S. Bakken. 2003. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin. Infect. Dis. 36:580-585.
2. Allison, S. D., and J. B. Martiny. 2008. Resistance, resilience, and redundancy in microbial communities. Proc. Natl. Acad. Sci. USA 105(Suppl. 1):11512-11519.
3. Bäckhed, F., R. E. Ley, J. L. Sonnenburg, D. A. Peterson, and J. I. Gordon. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-1920. (Pubitemid 40404694)
4. Bartlett, J. G. 2008. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin. Infect. Dis. 46(Suppl. 1):S4-S11.
5. Brandl, K., G. Plitas, C. N. Mihu, C. Ubeda, T. Jia, M. Fleisher, B. Schnabl, R. P. DeMatteo, and E. G. Pamer. 2008. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455:804-807.
6. Broekaert, I. J., and W. A. Walker. 2006. Probiotics and chronic disease. J. Clin. Gastroenterol. 40:270-274.
7. Chang, J. Y., D. A. Antonopoulos, A. Kalra, A. Tonelli, W. T. Khalife, T. M. Schmidt, and V. B. Young. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197:435-438.
8. Chao, A. 1984. Nonparametric estimation of the number of classes in a population. Scand. J. Stat. 11:265-270.
9. Chen, X., K. Katchar, J. D. Goldsmith, N. Nanthakumar, A. Cheknis, D. N. Gerding, and C. P. Kelly. 2008. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135:1984-1992.
10. De La Cochetière, M. F., T. Durand, V. Lalande, J. C. Petit, G. Potel, and L. Beaugerie. 2008. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb. Ecol. 56:395-402.
11. Dethlefsen, L., P. B. Eckburg, E. M. Bik, and D. A. Relman. 2006. Assembly of the human intestinal microbiota. Trends Ecol. Evol. 21:517-523.
12. Dethlefsen, L., S. Huse, M. L. Sogin, and D. A. Relman. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280.
13. Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson, and D. A. Relman. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638.
14. Edgar, R. C. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797. (Pubitemid 38832724)
15. Frank, D. N., and N. R. Pace. 2008. Gastrointestinal microbiology enters the metagenomics era. Curr. Opin. Gastroenterol. 24:4-10.
16. Freter, R. 1962. In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. II. The inhibitory mechanism. J. Infect. Dis. 110:38-46.
17. Gotelli, N. J., and R. K. Colwell. 2001. Quantifying biodiversity: procedures and pitfalls in the measurement and comparison of species richness. Ecol. Lett. 4:379-391.
18. Hentges, D. J., and R. Freter. 1962. In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests. J. Infect. Dis. 110:30-37.
19. Holdeman, L. V., I. J. Good, and W. E. Moore. 1976. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl. Environ. Microbiol. 31:359-375.
20. Hooper, L. V., J. Xu, P. G. Falk, T. Midtvedt, and J. I. Gordon. 1999. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. USA 96:9833-9838.
21. Huber, J. A., D. B. Mark Welch, H. G. Morrison, S. M. Huse, P. R. Neal, D. A. Butterfield, and M. L. Sogin. 2007. Microbial population structures in the deep marine biosphere. Science 318:97-100. (Pubitemid 47538040)
22. Huse, S. M., L. Dethlefsen, J. A. Huber, D. M. Welch, D. A. Relman, and M. L. Sogin. 2008. Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet. 4:e1000255.
23. Huse, S. M., J. A. Huber, H. G. Morrison, M. L. Sogin, and D. M. Welch. 2007. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 8:R143.
24. Ivanov, I. I., L. Frutos Rde, N. Manel, K. Yoshinaga, D. B. Rifkin, R. B. Sartor, B. B. Finlay, and D. R. Littman. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-349.
25. Jernberg, C., S. Löfmark, C. Edlund, and J. K. Jansson. 2007. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1:56-66. (Pubitemid 46717132)
26. Kang, S. S., S. M. Bloom, L. A. Norian, M. J. Geske, R. A. Flavell, T. S. Stappenbeck, and P. M. Allen. 2008. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med. 5:e41.
27. Kelly, D., and S. Conway. 2005. Bacterial modulation of mucosal innate immunity. Mol. Immunol. 42:895-901.
28. Ley, R. E., M. Hamady, C. Lozupone, P. J. Turnbaugh, R. R. Ramey, J. S. Bircher, M. L. Schlegel, T. A. Tucker, M. D. Schrenzel, R. Knight, and J. I. Gordon. 2008. Evolution of mammals and their gut microbes. Science 320:1647-1651.
29. Ley, R. E., D. A. Peterson, and J. I. Gordon. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-848. (Pubitemid 43261456)
30. Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-1023. (Pubitemid 46018512)
31. Little, A. E., C. J. Robinson, S. B. Peterson, K. F. Raffa, and J. Handelsman. 2008. Rules of engagement: interspecies interactions that regulate microbial communities. Annu. Rev. Microbiol. 62:375-401.
32. Löfmark, S., C. Jernberg, J. K. Jansson, and C. Edlund. 2006. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J. Antimicrob. Chemother. 58:1160-1167.
33. Madsen, K. L., J. S. Doyle, M. M. Tavernini, L. D. Jewell, R. P. Rennie, and R. N. Fedorak. 2000. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118:1094-1105. (Pubitemid 30346986)
34. Magurran, A. E. 2004. Measuring biological diversity. Blackwell Science Ltd., Oxford, United Kingdom.
35. Maroo, S., and J. T. Lamont. 2006. Recurrent Clostridium difficile. Gastroenterology 130:1311-1316.
36. Maukonen, J., R. Satokari, J. Matto, H. Soderlund, T. Mattila-Sandholm, and M. Saarela. 2006. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J. Med. Microbiol. 55:625-633.
37. Membrez, M., F. Blancher, M. Jaquet, R. Bibiloni, P. D. Cani, R. G. Burcelin, I. Corthesy, K. Mace, and C. J. Chou. 2008. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 22:2416-2426.
38. Mylonakis, E., E. T. Ryan, and S. B. Calderwood. 2001. Clostridium difficile-associated diarrhea: a review. Arch. Intern. Med. 161:525-533.
39. Nadkarni, M. A., F. E. Martin, N. A. Jacques, and N. Hunter. 2002. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148:257-266. (Pubitemid 34083204)
40. Nitsche, A., M. Becker, I. Junghahn, J. Aumann, O. Landt, I. Fichtner, B. Wittig, and W. Siegert. 2001. Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction. Haematologica 86:693-699. (Pubitemid 32680994)
41. Pace, N. R. 1997. A molecular view of microbial diversity and the biosphere. Science 276:734-740. (Pubitemid 27199842)
42. Peterson, D. A., D. N. Frank, N. R. Pace, and J. I. Gordon. 2008. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3:417-427.
43. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229-241. (Pubitemid 38962578)
44. Samuel, B. S., and J. I. Gordon. 2006. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc. Natl. Acad. Sci. USA 103:10011-10016.
45. Sanders, M. E. 2008. Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 46(Suppl. 2):S58-S61.
46. Sansonetti, P. J., and J. P. Di Santo. 2007. Debugging how bacteria manipulate the immune response. Immunity 26:149-161. (Pubitemid 46329442)
47. Sartor, R. B. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-594.
48. Savage, D. C. 1977. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31:107-133.
49. Scanlan, P. D., F. Shanahan, C. O'Mahony, and J. R. Marchesi. 2006. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J. Clin. Microbiol. 44:3980-3988.
50. Schloss, P. D., and J. Handelsman. 2005. Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl. Environ. Microbiol. 71:1501-1506.
51. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3:1101-1108.
52. Sekirov, I., N. M. Tam, M. Jogova, M. L. Robertson, Y. Li, C. Lupp, and B. B. Finlay. 2008. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76:4726-4736.
53. Shreiner, A., G. B. Huffnagle, and M. C. Noverr. 2008. The "microflora hypothesis" of allergic disease. Adv. Exp. Med. Biol. 635:113-134.
54. Sogin, M. L., H. G. Morrison, J. A. Huber, D. Mark Welch, S. M. Huse, P. R. Neal, J. M. Arrieta, and G. J. Herndl. 2006. Microbial diversity in the deep sea and the underexplored "rare biosphere." Proc. Natl. Acad. Sci. USA 103:12115-12120.
55. Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-1031. (Pubitemid 46018515)
56. Tvede, M., and J. Rask-Madsen. 1989. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet i:1156-1160. (Pubitemid 19138849)
57. Vanhoutte, T., V. De Preter, E. De Brandt, K. Verbeke, J. Swings, and G. Huys. 2006. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl. Environ. Microbiol. 72:5990-5997. (Pubitemid 44414627)
58. Vollaard, E. J., and H. A. Clasener. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.
59. Walker, W. A. 2008. Mechanisms of action of probiotics. Clin. Infect. Dis. 46(Suppl. 2):S87-S91.
60. Wilson, K. H. 1993. The microecology of Clostridium difficile. Clin. Infect. Dis. 16(Suppl. 4):S214-S218.
61. Wilson, K. H., and R. B. Blitchington. 1996. Human colonic biota studied by ribosomal DNA sequence analysis. Appl. Environ. Microbiol. 62:2273-2278.
62. Zoetendal, E. G., A. D. Akkermans, and W. M. De Vos. 1998. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 64:3854-3859.